{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:19:01Z","timestamp":1789593541601,"version":"build-2803163510"},"reference-count":151,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["220Z074"],"award-info":[{"award-number":["220Z074"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"award":["220Z074"],"award-info":[{"award-number":["220Z074"]}],"id":[{"id":"https:\/\/ror.org\/04w9kkr77","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Epitranscriptomic modifications, particularly RNA methylations, have emerged as regulators of gene expression, with their dysregulation acting as a key factor in tumorigenesis and metastatic progression. This review evaluates the therapeutic landscapes of N6-methyladenosine (m6A) and N1-methyladenosine (m1A) modifications in cancer. While the m6A machinery predominantly dictates mRNA turnover and stability, the m1A network is uniquely positioned to drive translational reprogramming, allowing malignant cells to endure severe microenvironmental stress and evade cell death. Despite positional and chemical differences, these modifications exhibit profound epitranscriptomic crosstalk through shared regulatory proteins. Here, we comprehensively analyze current pharmacological strategies targeting the m6A axis, highlighting the transition from classical small-molecule inhibitors of regulatory proteins of these methylations, such as methyltransferase-like 3 (METTL3), fat mass and obesity-associated protein (FTO), and AlkB homolog 5 (ALKBH5), to the novel event-driven approach of proteolysis-targeting chimeras (PROTACs). Furthermore, we assess the emerging therapeutic potential of the m1A regulatory machinery, positioning tRNA methyltransferase 6\/61A (TRMT6\/61A) writers and AlkB homolog 1 to 3 (ALKBH1-3) erasers as promising therapeutic targets. Finally, we discuss clinical successes and current translational obstacles, including off-target toxicity, pharmacokinetic limitations, and epitranscriptomic escape, emphasizing that site-specific modulation and smart precision therapies will dictate the future of oncology.<\/jats:p>","DOI":"10.3390\/ph19070990","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:50:33Z","timestamp":1782924633000},"page":"990","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["m1A and m6A RNA Methylations as Druggable Targets in Cancer"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6395-5627","authenticated-orcid":false,"given":"Yasemin","family":"Gazalo\u011flu","sequence":"first","affiliation":[{"name":"Noncoding RNA Laboratory, Department of Molecular Biology and Genetics, \u0130zmir Institute of Technology, 35430 Izmir, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9991-3042","authenticated-orcid":false,"given":"Buket","family":"Sa\u011flam-\u015een","sequence":"additional","affiliation":[{"name":"Noncoding RNA Laboratory, Department of Molecular Biology and Genetics, \u0130zmir Institute of Technology, 35430 Izmir, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9877-9689","authenticated-orcid":false,"given":"B\u00fcnyamin","family":"Akg\u00fcl","sequence":"additional","affiliation":[{"name":"Noncoding RNA Laboratory, Department of Molecular Biology and Genetics, \u0130zmir Institute of Technology, 35430 Izmir, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/gb-2012-13-10-175","article-title":"The Birth of the Epitranscriptome: Deciphering the Function of RNA Modifications","volume":"13","author":"Saletore","year":"2012","journal-title":"Genome Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrg.2016.59","article-title":"The Molecular Hallmarks of Epigenetic Control","volume":"17","author":"Allis","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.aau1646","article-title":"RNA Modifications Modulate Gene Expression during Development","volume":"361","author":"Frye","year":"2018","journal-title":"Science"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"D231","DOI":"10.1093\/nar\/gkab1083","article-title":"MODOMICS: A Database of RNA Modification Pathways. 2021 Update","volume":"50","author":"Boccaletto","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.cell.2017.05.045","article-title":"Dynamic RNA Modifications in Gene Expression Regulation","volume":"169","author":"Roundtree","year":"2017","journal-title":"Cell"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature12730","article-title":"N6-Methyladenosine-Dependent Regulation of Messenger RNA Stability","volume":"505","author":"Wang","year":"2014","journal-title":"Nature"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.molcel.2016.01.012","article-title":"Nuclear M6A Reader YTHDC1 Regulates MRNA Splicing","volume":"61","author":"Xiao","year":"2016","journal-title":"Mol. Cell"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e31311","DOI":"10.7554\/eLife.31311","article-title":"YTHDC1 Mediates Nuclear Export of N6-Methyladenosine Methylated MRNAs","volume":"6","author":"Roundtree","year":"2017","journal-title":"Elife"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","article-title":"N6-Methyladenosine Modulates Messenger RNA Translation Efficiency","volume":"161","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","article-title":"Role of RNA Modifications in Cancer","volume":"20","author":"Barbieri","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","article-title":"The Role of M6A Modification in the Biological Functions and Diseases","volume":"6","author":"Jiang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.tcb.2024.08.002","article-title":"RNA M6A Methylation at the Juxtaposition of Apoptosis and RNA Therapeutics","volume":"34","year":"2024","journal-title":"Trends Cell Biol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Sa\u011flam, B., Akku\u015f, O., Ak\u00e7a\u00f6z-Alasar, A., Ceylan, \u00c7., G\u00fcler, G., and Akg\u00fcl, B. (2024). An Investigation of RNA Methylations with Biophysical Approaches in a Cervical Cancer Cell Model. Cells, 13.","DOI":"10.3390\/cells13221832"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ccell.2020.02.004","article-title":"M6A Modification in Coding and Non-Coding RNAs: Roles and Therapeutic Implications in Cancer","volume":"37","author":"Huang","year":"2020","journal-title":"Cancer Cell"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1021\/acs.accounts.3c00529","article-title":"General Principles and Limitations for Detection of RNA Modifications by Sequencing","volume":"57","author":"Motorin","year":"2024","journal-title":"Acc. Chem. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1111\/febs.70393","article-title":"Linking RNA Methylation to Structure: A Biophysical Perspective","volume":"293","year":"2026","journal-title":"FEBS J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1073\/pnas.71.10.3971","article-title":"Identification of Methylated Nucleosides in Messenger RNA from Novikoff Hepatoma Cells","volume":"71","author":"Desrosiers","year":"1974","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.cell.2012.05.003","article-title":"Comprehensive Analysis of MRNA Methylation Reveals Enrichment in 3\u2032 UTRs and near Stop Codons","volume":"149","author":"Meyer","year":"2012","journal-title":"Cell"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature11112","article-title":"Topology of the Human and Mouse M6A RNA Methylomes Revealed by M6A-Seq","volume":"485","author":"Dominissini","year":"2012","journal-title":"Nature"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0006-3002(61)90668-0","article-title":"The Occurence of 1-Methyladenine in Ribonucleic Acid","volume":"46","author":"Dunn","year":"1961","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/1878-0261.13366","article-title":"ALKBH1-Mediated M1 A Demethylation of METTL3 MRNA Promotes the Metastasis of Colorectal Cancer by Downregulating SMAD7 Expression","volume":"17","author":"Chen","year":"2023","journal-title":"Mol. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nsmb.3270","article-title":"M1A and M1G Disrupt A-RNA Structure through the Intrinsic Instability of Hoogsteen Base Pairs","volume":"23","author":"Zhou","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature24456","article-title":"The M1A Landscape on Cytosolic and Mitochondrial MRNA at Single-Base Resolution","volume":"551","author":"Safra","year":"2017","journal-title":"Nature"},{"key":"ref_24","first-page":"429","article-title":"Advances in the Structural and Functional Understanding of M1A RNA Modification","volume":"57","author":"Smoczynski","year":"2024","journal-title":"Acc. Chem. Res."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Anderson, J.T., and Droogmans, L. (2005). Biosynthesis and Function of 1-Methyladenosine in Transfer RNA. Fine-Tuning of RNA Functions by Modification and Editing, Springer.","DOI":"10.1007\/b106364"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1101\/gad.1183804","article-title":"Nuclear Surveillance and Degradation of Hypomodified Initiator TRNAMet in S. Cerevisiae","volume":"18","author":"Kadaba","year":"2004","journal-title":"Genes Dev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.molcel.2017.10.019","article-title":"Base-Resolution Mapping Reveals Distinct M1A Methylome in Nuclear- and Mitochondrial-Encoded Transcripts","volume":"68","author":"Li","year":"2017","journal-title":"Mol. Cell"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1261\/rna.035600.112","article-title":"Trmt61B Is a Methyltransferase Responsible for 1-Methyladenosine at Position 58 of Human Mitochondrial TRNAs","volume":"18","author":"Chujo","year":"2012","journal-title":"RNA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"11583","DOI":"10.1093\/nar\/gks910","article-title":"A Subcomplex of Human Mitochondrial RNase P Is a Bifunctional Methyltransferase\u2014Extensive Moonlighting in Mitochondrial TRNA Biogenesis","volume":"40","author":"Vilardo","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nature01363","article-title":"Human and Bacterial Oxidative Demethylases Repair Alkylation Damage in Both RNA and DNA","volume":"421","author":"Aas","year":"2003","journal-title":"Nature"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.cell.2016.09.038","article-title":"ALKBH1-Mediated TRNA Demethylation Regulates Translation","volume":"167","author":"Liu","year":"2016","journal-title":"Cell"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.molcel.2018.08.011","article-title":"Differential M6A, M6Am, and M1A Demethylation Mediated by FTO in the Cell Nucleus and Cytoplasm","volume":"71","author":"Wei","year":"2018","journal-title":"Mol. Cell"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"6380","DOI":"10.1021\/acs.analchem.8b01703","article-title":"Identification of YTH Domain-Containing Proteins as the Readers for N1-Methyladenosine in RNA","volume":"90","author":"Dai","year":"2018","journal-title":"Anal. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41698-026-01361-w","article-title":"TRMT6-Directed M1A Modification Initiates Lung Squamous Cell Carcinoma via YTHDF3-Stabilized Cell Cycle Genes","volume":"10","author":"Xue","year":"2026","journal-title":"NPJ Precis. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1093\/nar\/gky1250","article-title":"Transfer RNA Demethylase ALKBH3 Promotes Cancer Progression via Induction of TRNA-Derived Small RNAs","volume":"47","author":"Chen","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Monshaugen, I., Luna, L., Rhodes, J., Kristiansen, F.I.S., L\u00e5ng, A., B\u00f8e, S.O., Dutta, A., Su, Z., Klungland, A., and Ougland, R. (2024). Depletion of the M1A Writer TRMT6\/TRMT61A Reduces Proliferation and Resistance against Cellular Stress in Bladder Cancer. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1334112"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nchembio.1432","article-title":"A METTL3\u2013METTL14 Complex Mediates Mammalian Nuclear RNA N6-Adenosine Methylation","volume":"10","author":"Liu","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"ref_38","first-page":"1233","article-title":"Purification and CDNA Cloning of the AdoMet-Binding Subunit of the Human MRNA (N6-Adenosine)-Methyltransferase","volume":"3","author":"Bokar","year":"1997","journal-title":"RNA"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nature18298","article-title":"Structural Basis of N6-Adenosine Methylation by the METTL3\u2013METTL14 Complex","volume":"534","author":"Wang","year":"2016","journal-title":"Nature"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/cr.2014.3","article-title":"Mammalian WTAP Is a Regulatory Subunit of the RNA N6-Methyladenosine Methyltransferase","volume":"24","author":"Ping","year":"2014","journal-title":"Cell Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41421-018-0019-0","article-title":"VIRMA Mediates Preferential M6A MRNA Methylation in 3\u2032UTR and near Stop Codon and Associates with Alternative Polyadenylation","volume":"4","author":"Yue","year":"2018","journal-title":"Cell Discov."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nature19342","article-title":"M6A RNA Methylation Promotes XIST-Mediated Transcriptional Repression","volume":"537","author":"Patil","year":"2016","journal-title":"Nature"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.molcel.2012.10.015","article-title":"ALKBH5 Is a Mammalian RNA Demethylase That Impacts RNA Metabolism and Mouse Fertility","volume":"49","author":"Zheng","year":"2013","journal-title":"Mol. Cell"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1038\/ncomms2822","article-title":"FTO-Mediated Formation of N6-Hydroxymethyladenosine and N6-Formyladenosine in Mammalian RNA","volume":"4","author":"Fu","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nchembio.687","article-title":"N6-Methyladenosine in Nuclear RNA Is a Major Substrate of the Obesity-Associated FTO","volume":"7","author":"Jia","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","article-title":"Recognition of RNA N6-Methyladenosine by IGF2BP Proteins Enhances MRNA Stability and Translation","volume":"20","author":"Huang","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nature14234","article-title":"N6-Methyladenosine-Dependent RNA Structural Switches Regulate RNA\u2013Protein Interactions","volume":"518","author":"Liu","year":"2015","journal-title":"Nature"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1093\/nar\/gkx141","article-title":"N 6-Methyladenosine Alters RNA Structure to Regulate Binding of a Low-Complexity Protein","volume":"45","author":"Liu","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Ak\u00e7a\u00f6z-Alasar, A., Parrado, C.A.R., Villalobos, D., Wang, Y., Boddu, P.C., Nguyen, A.H., Li, H., Perez-Pepe, M., Darnat, P., and Liu, Y. (2025). METTL3 Promotes Cell Cycle Progression via Activation of Transcriptional Elongation. bioRxiv.","DOI":"10.1101\/2025.07.12.664541"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Alasar, A.A., T\u00fcncel, \u00d6., Gelmez, A.B., Sa\u011flam, B., Vatansever, \u0130.E., and Akg\u00fcl, B. (2022). Genomewide M6A Mapping Uncovers Dynamic Changes in the M6A Epitranscriptome of Cisplatin-Treated Apoptotic HeLa Cells. Cells, 11.","DOI":"10.3390\/cells11233905"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e31176","DOI":"10.1002\/jcp.31176","article-title":"Epitranscriptomics M6A Analyses Reveal Distinct M6A Marks under Tumor Necrosis Factor \u03b1 (TNF-\u03b1)-Induced Apoptotic Conditions in HeLa Cells","volume":"239","author":"Atbinek","year":"2024","journal-title":"J. Cell. Physiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/s41590-022-01301-3","article-title":"TRNA-M1A Modification Promotes T Cell Expansion via Efficient MYC Protein Synthesis","volume":"23","author":"Liu","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nature16998","article-title":"The Dynamic N1-Methyladenosine Methylome in Eukaryotic Messenger RNA","volume":"530","author":"Dominissini","year":"2016","journal-title":"Nature"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2451446","DOI":"10.1080\/16078454.2025.2451446","article-title":"ALKBH3-Mediated M1A Demethylation Promotes the Malignant Progression of Acute Myeloid Leukemia by Regulating Ferroptosis through the Upregulation of ATF4 Expression","volume":"30","author":"Liu","year":"2025","journal-title":"Hematology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1021\/acscentsci.2c00565","article-title":"Molecular Simulations Matching Denaturation Experiments for N 6 -Methyladenosine","volume":"8","author":"Piomponi","year":"2022","journal-title":"ACS Cent. Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/jb\/mvaa026","article-title":"N 1-Methyladenosine (M1A) RNA Modification: The Key to Ribosome Control","volume":"167","author":"Shima","year":"2020","journal-title":"J. Biochem."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Wang, X., Ma, X., Chen, S., Fan, M., Jin, C., Chen, Y., Wang, S., Wang, Z., Meng, F., and Zhang, C. (2024). Harnessing M1A Modification: A New Frontier in Cancer Immunotherapy. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1517604"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1080\/15548627.2025.2493455","article-title":"METTL3-Dependent m 6 A Modification of SNAP29 Induces \u201cAutophagy-Mitochondrial Crisis\u201d in the Ischemic Microenvironment after Soft Tissue Transplantation","volume":"21","author":"Yang","year":"2025","journal-title":"Autophagy"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1021\/acschembio.2c00178","article-title":"Development of Mild Chemical Catalysis Conditions for M1A-to-M6A Rearrangement on RNA","volume":"17","author":"Liu","year":"2022","journal-title":"ACS Chem. Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1261\/rna.079966.124","article-title":"Chemical Manipulation of M1A Mediates Its Detection in Human TRNA","volume":"30","author":"Pajdzik","year":"2024","journal-title":"RNA"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/cmdc.202000011","article-title":"Small-Molecule Inhibitors of METTL3, the Major Human Epitranscriptomic Writer","volume":"15","author":"Bedi","year":"2020","journal-title":"ChemMedChem"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.cell.2013.10.026","article-title":"RNA-Methylation-Dependent RNA Processing Controls the Speed of the Circadian Clock","volume":"155","author":"Fustin","year":"2013","journal-title":"Cell"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1016\/S0021-9258(17)43053-5","article-title":"A Potent Inhibitor of S-Adenosylhomocysteine Hydrolase and of Vaccinia Virus Multiplication in Mouse L929 Cells","volume":"259","author":"Borchardt","year":"1984","journal-title":"J. Biol. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0026-895X(25)15050-5","article-title":"Effects of Adenosine Dialdehyde on S-Adenosylhomocysteine Hydrolase and S-Adenosylmethionine-Dependent Transmethylations in Mouse L929 Cells","volume":"25","author":"Bartel","year":"1984","journal-title":"Mol. Pharmacol."},{"key":"ref_65","first-page":"255","article-title":"Evaluation of Sinefungin for the Treatment of Trypanosoma (Nannomonas) Congolense Infections in Goats","volume":"37","author":"Zweygarth","year":"1986","journal-title":"Trop. Med. Parasitol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/bs.mie.2016.01.009","article-title":"Synthesis and Assays of Inhibitors of Methyltransferases","volume":"Volume 574","author":"Cai","year":"2016","journal-title":"Methods in Enzymology"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1016\/j.bmcl.2009.03.113","article-title":"SAR around (l)-S-Adenosyl-l-Homocysteine, an Inhibitor of Human DNA Methyltransferase (DNMT) Enzymes","volume":"19","author":"Saavedra","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1021\/jm00231a003","article-title":"Potential Inhibitors of S-Adenosylmethionine-Dependent Methyltransferases. 4. Further Modifications of the Amino Acid and Base Portions of S-Adenosyl-L-Homocysteine","volume":"19","author":"Borchardt","year":"1976","journal-title":"J. Med. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1002\/cmdc.202100291","article-title":"METTL3 Inhibitors for Epitranscriptomic Modulation of Cellular Processes","volume":"16","author":"Huang","year":"2021","journal-title":"ChemMedChem"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"12738","DOI":"10.1021\/acs.jmedchem.1c00773","article-title":"1,4,9-Triazaspiro [5.5]Undecan-2-One Derivatives as Potent and Selective METTL3 Inhibitors","volume":"64","author":"Dolbois","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","article-title":"Small-Molecule Inhibition of METTL3 as a Strategy against Myeloid Leukaemia","volume":"593","author":"Yankova","year":"2021","journal-title":"Nature"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Sun, H., Xu, H., Li, J., Xie, X., Zhang, J., Dong, H., Xie, H., Wang, Q., Zhao, G., and Yin, K. (2026). The METTL3 Inhibitor STM2457 Suppresses Gastric Cancer Progression by Modulating M6A RNA Modification. PLoS ONE, 21.","DOI":"10.1371\/journal.pone.0345744"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.7150\/jca.96760","article-title":"METTL3 Inhibition Suppresses Cell Growth and Survival in Colorectal Cancer via ASNS Downregulation","volume":"15","author":"Yu","year":"2024","journal-title":"J. Cancer"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.7150\/ijbs.97425","article-title":"Targeting METTL3 Enhances the Chemosensitivity of Non-Small Cell Lung Cancer Cells by Decreasing ABCC2 Expression in an m 6 A-YTHDF1-Dependent Manner","volume":"20","author":"Zhang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Kim, U., Li, J., Matei, D., and Huang, H. (2026). Epitranscriptomic Regulation of Platinum Resistance via the METTL3-ADAM23 Axis in Ovarian Cancer. Cells, 15.","DOI":"10.3390\/cells15030294"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.immuni.2020.05.003","article-title":"M6A Modification Prevents Formation of Endogenous Double-Stranded RNAs and Deleterious Innate Immune Responses during Hematopoietic Development","volume":"52","author":"Gao","year":"2020","journal-title":"Immunity"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1158\/2159-8290.CD-23-0007","article-title":"Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity","volume":"13","author":"Guirguis","year":"2023","journal-title":"Cancer Discov."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"8567","DOI":"10.21037\/tcr-2025-1429","article-title":"Targeting the METTL3\/PCNA Axis with STM2457 Overcomes Cisplatin Resistance in Osteosarcoma","volume":"14","author":"Yu","year":"2025","journal-title":"Transl. Cancer Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/S0959-8049(22)01128-5","article-title":"STC-15, an Oral Small Molecule Inhibitor of the RNA Methyltransferase METTL3, Inhibits Tumour Growth through Activation of Anti-Cancer Immune Responses Associated with Increased Interferon Signalling, and Synergises with T Cell Checkpoint Blockade","volume":"174","author":"Saunders","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1038\/s41375-022-01696-w","article-title":"METTL3 Mediates Chemoresistance by Enhancing AML Homing and Engraftment via ITGA4","volume":"36","author":"Li","year":"2022","journal-title":"Leukemia"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Vasiliauskaite, L., Ofir-Rosenfeld, Y., Albertella, M., Hoareau-Aveilla, C., McMahon, J., and Rausch, O. (2023). Abstract A18: STC-15, a Novel METTL3 Inhibitor, and Its Combination with Venetoclax Confer Anti-Tumour Activity in AML Models. Blood Cancer Discov., 4.","DOI":"10.1158\/2643-3249.AML23-A18"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Fischl, H., Samuels, T.J., Andrews, B., Vasiliauskait\u0117, L., Jupp, D., Saunders, C.J., Obacz, J., Ofir-Rosenfeld, Y., and Rausch, O. (2025). Inhibition of METTL3 by STC-15 Induces RNA Misprocessing That Results in DsRNA Formation and Activates Innate Immunity. bioRxiv.","DOI":"10.64898\/2025.12.05.692335"},{"key":"ref_83","unstructured":"STORM Therapeutics, Ltd. (2026). Oral Administration of STC-15 in Subjects with Advanced Malignancies, STORM Therapeutics, Ltd."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1200\/JCO.2024.42.16_suppl.2586","article-title":"Phase 1 Dose Escalation and Cohort Expansion Study Evaluating Safety, PK, PD and Clinical Activity of STC-15, a METTL-3 Inhibitor, in Patients with Advanced Malignancies","volume":"42","author":"Moser","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"ref_85","unstructured":"ClinicalTrials.gov (2026, June 12). STC-15 as a Part of Combination Therapy with Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants with Selected Sarcomas. Identifier NCT06975293, Available online: https:\/\/clinicaltrials.gov\/study\/NCT06975293."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41571-019-0218-0","article-title":"Adverse Effects of Immune-Checkpoint Inhibitors: Epidemiology, Management and Surveillance","volume":"16","author":"Martins","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.celrep.2017.04.031","article-title":"Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression","volume":"19","author":"Shin","year":"2017","journal-title":"Cell Rep."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1021\/acs.jmedchem.4c02225","article-title":"Discovery, Optimization, and Preclinical Pharmacology of EP652, a METTL3 Inhibitor with Efficacy in Liquid and Solid Tumor Models","volume":"68","author":"Dutheuil","year":"2025","journal-title":"J. Med. Chem."},{"key":"ref_89","unstructured":"ClinicalTrials.gov (2026, June 12). EP102 Safety and Efficacy in METTL3 Modulation in Advanced Solid Tumors. Identifier NCT07163325, Available online: https:\/\/clinicaltrials.gov\/study\/NCT07163325."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"17963","DOI":"10.1021\/ja3064149","article-title":"Development of Cell-Active N6-Methyladenosine RNA Demethylase FTO Inhibitor","volume":"134","author":"Chen","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/nar\/gku1276","article-title":"Meclofenamic Acid Selectively Inhibits FTO Demethylation of M6A over ALKBH5","volume":"43","author":"Huang","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1016\/j.celrep.2017.02.059","article-title":"M6A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells","volume":"18","author":"Cui","year":"2017","journal-title":"Cell Rep."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ccell.2019.03.006","article-title":"Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia","volume":"35","author":"Huang","year":"2019","journal-title":"Cancer Cell"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cell.2017.11.031","article-title":"R-2HG Exhibits Anti-Tumor Activity by Targeting FTO\/M6A\/MYC\/CEBPA Signaling","volume":"172","author":"Su","year":"2018","journal-title":"Cell"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.cmet.2021.04.001","article-title":"Tumors Exploit FTO-Mediated Regulation of Glycolytic Metabolism to Evade Immune Surveillance","volume":"33","author":"Liu","year":"2021","journal-title":"Cell Metab."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"13714","DOI":"10.1021\/acs.jmedchem.5c00566","article-title":"Development of Orally Bioavailable FTO Inhibitors with Potent Antileukemia Efficacy","volume":"68","author":"Yang","year":"2025","journal-title":"J. Med. Chem."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.molcel.2020.05.034","article-title":"Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy","volume":"78","author":"Bader","year":"2020","journal-title":"Mol. Cell"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1016\/j.apsb.2024.07.016","article-title":"Discovery of a Potent PROTAC Degrader for RNA Demethylase FTO as Antileukemic Therapy","volume":"14","author":"Liu","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_99","first-page":"1402","article-title":"Bisantrene, an Active New Drug in the Treatment of Metastatic Breast Cancer","volume":"43","author":"Yap","year":"1983","journal-title":"Cancer Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ccell.2020.04.017","article-title":"Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion","volume":"38","author":"Su","year":"2020","journal-title":"Cancer Cell"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/bjc.1992.46","article-title":"In Vitro and in Vivo Studies on the Combination of Brequinar Sodium (DUP-785; NSC 368390) with 5-Fluorouracil; Effects of Uridine","volume":"65","author":"Peters","year":"1992","journal-title":"Br. J. Cancer"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"15944","DOI":"10.1021\/acs.jmedchem.3c01374","article-title":"Discovery of Pyrazolo[1,5-a]Pyrimidine Derivative as a Novel and Selective ALKBH5 Inhibitor for the Treatment of AML","volume":"66","author":"Wang","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1039\/D3CB00230F","article-title":"A Covalent Compound Selectively Inhibits RNA Demethylase ALKBH5 Rather than FTO","volume":"5","author":"Lai","year":"2024","journal-title":"RSC Chem. Biol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1021\/acscentsci.2c00107","article-title":"Allosteric Regulation of IGF2BP1 as a Novel Strategy for the Activation of Tumor Immune Microenvironment","volume":"8","author":"Liu","year":"2022","journal-title":"ACS Cent. Sci."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"12931","DOI":"10.1021\/acs.jmedchem.3c00872","article-title":"Discovery of Triazolyl Derivatives of Cucurbitacin B Targeting IGF2BP1 against Non-Small Cell Lung Cancer","volume":"66","author":"Shang","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1158\/0008-5472.CAN-21-4249","article-title":"The RNA M6A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression","volume":"83","author":"Hong","year":"2023","journal-title":"Cancer Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"e202509316","DOI":"10.1002\/anie.202509316","article-title":"Identification of a Selective YTHDF1 Inhibitor Targeting the m 6 A Recognition Domain for Breast Cancer","volume":"64","author":"Wu","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1039\/D4CB00105B","article-title":"Discovery of a New Inhibitor for YTH Domain-Containing M6A RNA Readers","volume":"5","author":"Wang","year":"2024","journal-title":"RSC Chem. Biol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1021\/jacsau.4c00754","article-title":"Phenylpyrazoles as Inhibitors of the M6A RNA-Binding Protein YTHDF2","volume":"5","author":"Qiu","year":"2025","journal-title":"JACS Au"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1021\/acschembio.9b00655","article-title":"YTHDF2 Recognition of N1-Methyladenosine (M1A)-Modified RNA Is Associated with Transcript Destabilization","volume":"15","author":"Seo","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00018-024-05503-w","article-title":"YTHDF2-Dependent M6A Modification of FOXO3 MRNA Mediates TIMP1 Expression and Contributes to Intervertebral Disc Degeneration Following ROS Stimulation","volume":"81","author":"Wang","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.ccell.2023.04.019","article-title":"YTHDF2 Inhibition Potentiates Radiotherapy Antitumor Efficacy","volume":"41","author":"Wang","year":"2023","journal-title":"Cancer Cell"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41375-024-02451-z","article-title":"YTHDC1 Is a Therapeutic Target for B-Cell Acute Lymphoblastic Leukemia by Attenuating DNA Damage Response through the KMT2C-H3K4me1\/Me3 Epigenetic Axis","volume":"39","author":"Li","year":"2025","journal-title":"Leukemia"},{"key":"ref_114","unstructured":"Epizyme, Inc. (2026, June 12). A Phase 1, Open-Label, Dose-Escalation & Expanded Cohort, Continuous IV Infusion, Multi-Center Study of the Safety, Tolerability, PK & PD of EPZ-5676 in Treatment Relapsed\/Refractory Patients with Leukemias Involving. ClinicalTrials.Gov ID NCT01684150, Available online: https:\/\/Clinicaltrials.Gov\/Study\/NCT01684150."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1182\/blood-2017-12-818948","article-title":"The DOT1L Inhibitor Pinometostat Reduces H3K79 Methylation and Has Modest Clinical Activity in Adult Acute Leukemia","volume":"131","author":"Stein","year":"2018","journal-title":"Blood"},{"key":"ref_116","unstructured":"National Cancer Institute (NCI) (2026, June 12). Pinometostat and Azacitidine in Treating Patients with Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia with 11q23 Rearrangement. ClinicalTrials.Gov ID NCT03701295, Available online: https:\/\/Clinicaltrials.Gov\/Study\/NCT03701295."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"eadu3137","DOI":"10.1126\/scitranslmed.adu3137","article-title":"Small-Molecule Inhibition of YTHDC1 as a Strategy against Acute Myeloid Leukemia in Mouse Models","volume":"18","author":"Zhang","year":"2026","journal-title":"Sci. Transl. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cell.2019.11.031","article-title":"Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery","volume":"181","author":"Burslem","year":"2020","journal-title":"Cell"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC Targeted Protein Degraders: The Past Is Prologue","volume":"21","author":"Langley","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1021\/jacsau.4c00040","article-title":"Proteolysis Targeting Chimera Degraders of the METTL3\u201314 M6A-RNA Methyltransferase","volume":"4","author":"Errani","year":"2024","journal-title":"JACS Au"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.chembiol.2023.12.009","article-title":"Discovery of a PROTAC Degrader for METTL3-METTL14 Complex","volume":"31","author":"Du","year":"2024","journal-title":"Cell Chem. Biol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"101452","DOI":"10.1016\/j.gendis.2024.101452","article-title":"Targeting METTL3 Protein by Proteolysis-Targeting Chimeras: A Novel Therapeutic Approach for Acute Myeloid Leukemia","volume":"12","author":"Nar","year":"2025","journal-title":"Genes Dis."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"116843","DOI":"10.1016\/j.ejmech.2024.116843","article-title":"Targeted Degradation of METTL3 against Acute Myeloid Leukemia and Gastric Cancer","volume":"279","author":"Hwang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1039\/D5MD00359H","article-title":"Structure-Guided Design of a Methyltransferase-like 3 (METTL3) Proteolysis Targeting Chimera (PROTAC) Incorporating an Indole\u2013Nicotinamide Chemotype","volume":"16","author":"Weldert","year":"2025","journal-title":"RSC Med. Chem."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"eadv7648","DOI":"10.1126\/sciadv.adv7648","article-title":"FTO Degrader Impairs Ribosome Biogenesis and Protein Translation in Acute Myeloid Leukemia","volume":"11","author":"Li","year":"2025","journal-title":"Sci. Adv."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Benak, D., Sevcikova, A., Holzerova, K., and Hlavackova, M. (2024). FTO in Health and Disease. Front. Cell Dev. Biol., 12.","DOI":"10.3389\/fcell.2024.1500394"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Syahputra, E.W., Lee, H., Cho, H., Park, H.J., Park, K.-S., and Hwang, D. (2025). PROTAC Delivery Strategies for Overcoming Physicochemical Properties and Physiological Barriers in Targeted Protein Degradation. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17040501"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e202400183","DOI":"10.1002\/cbic.202400183","article-title":"Profiling Cellular Morphological Changes Induced by Dual-Targeting PROTACs of Aurora Kinase and RNA-Binding Protein YTHDF2","volume":"25","author":"Goebel","year":"2024","journal-title":"ChemBioChem"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1002\/anie.202012330","article-title":"RNA-PROTACs: Degraders of RNA-Binding Proteins","volume":"60","author":"Ghidini","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"6741","DOI":"10.1021\/jacs.8b01233","article-title":"Small Molecule Targeted Recruitment of a Nuclease to RNA","volume":"140","author":"Costales","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41368-024-00304-0","article-title":"M1A Inhibition Fuels Oncolytic Virus-Elicited Antitumor Immunity via Downregulating MYC\/PD-L1 Signaling","volume":"16","author":"Li","year":"2024","journal-title":"Int. J. Oral Sci."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1038\/s41467-024-48032-7","article-title":"Fn-OMV Potentiates ZBP1-Mediated PANoptosis Triggered by Oncolytic HSV-1 to Fuel Antitumor Immunity","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","article-title":"The MYC Oncogene\u2014the Grand Orchestrator of Cancer Growth and Immune Evasion","volume":"19","author":"Dhanasekaran","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1021\/jm501234a","article-title":"Selective Inhibitors of Protein Methyltransferases","volume":"58","author":"Kaniskan","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s44259-024-00040-9","article-title":"Sinefungin, a Natural Nucleoside Analog of S-Adenosyl Methionine, Impairs the Pathogenicity of Candida Albicans","volume":"2","author":"Nayak","year":"2024","journal-title":"NPJ Antimicrob. Resist."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1002\/cac2.70070","article-title":"RNA M1A Methyltransferase TRMT61A Promotes Colorectal Tumorigenesis by Enhancing ONECUT2 MRNA Stability and Is a Potential Therapeutic Target","volume":"45","author":"Zhang","year":"2025","journal-title":"Cancer Commun."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1021\/acschemneuro.3c00576","article-title":"Small Molecules N-Phenylbenzofuran-2-Carboxamide and N-Phenylbenzo[b]Thiophene-2-Carboxamide Promote Beta-Amyloid (A\u03b242) Aggregation and Mitigate Neurotoxicity","volume":"14","author":"Zhao","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Sa\u011flam, B., and Akg\u00fcl, B. (2024). An Overview of Current Detection Methods for RNA Methylation. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25063098"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.bmcl.2014.01.008","article-title":"Design and Synthesis of Prostate Cancer Antigen-1 (PCA-1\/ALKBH3) Inhibitors as Anti-Prostate Cancer Drugs","volume":"24","author":"Nakao","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_140","first-page":"39","article-title":"Improving the Bioavailability and Anticancer Effect of the PCA-1\/ALKBH3 Inhibitor HUHS015 Using Sodium Salt","volume":"29","author":"Mabuchi","year":"2015","journal-title":"In Vivo"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"e2416046122","DOI":"10.1073\/pnas.2416046122","article-title":"Feedback Regulation between Histone Lactylation and ALKBH3-Mediated Glycolysis Regulates Age-Related Macular Degeneration Pathology","volume":"122","author":"Wang","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"11083","DOI":"10.1074\/jbc.M115.711895","article-title":"Rhein Inhibits AlkB Repair Enzymes and Sensitizes Cells to Methylated DNA Damage","volume":"291","author":"Li","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"13249","DOI":"10.1038\/s41598-019-49550-x","article-title":"ALKBH Overexpression in Head and Neck Cancer: Potential Target for Novel Anticancer Therapy","volume":"9","author":"Marcinkowski","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.celrep.2015.11.029","article-title":"Oncometabolite D-2-Hydroxyglutarate Inhibits ALKBH DNA Repair Enzymes and Sensitizes IDH Mutant Cells to Alkylating Agents","volume":"13","author":"Wang","year":"2015","journal-title":"Cell Rep."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s43556-023-00139-x","article-title":"RNA Modification: Mechanisms and Therapeutic Targets","volume":"4","author":"Qiu","year":"2023","journal-title":"Mol. Biomed."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1021\/acs.chemrestox.7b00009","article-title":"Oncometabolites D- and l-2-Hydroxyglutarate Inhibit the AlkB Family DNA Repair Enzymes under Physiological Conditions","volume":"30","author":"Chen","year":"2017","journal-title":"Chem. Res. Toxicol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"6992","DOI":"10.1021\/jacs.4c00194","article-title":"Discovery of a Potent and Cell-Active Inhibitor of DNA 6mA Demethylase ALKBH1","volume":"146","author":"Xiong","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"5684","DOI":"10.1093\/nar\/gkaa269","article-title":"Targeted MRNA Demethylation Using an Engineered DCas13b-ALKBH5 Fusion Protein","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/s41587-020-0572-6","article-title":"Programmable M6A Modification of Cellular RNAs with a Cas13-Directed Methyltransferase","volume":"38","author":"Wilson","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"e1907301","DOI":"10.1002\/smll.201907301","article-title":"Photoactivatable RNA N6-Methyladenosine Editing with CRISPR-Cas13","volume":"16","author":"Zhao","year":"2020","journal-title":"Small"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12943-020-01281-8","article-title":"N6-Methyladenosine-Modified CircRNA-SORE Sustains Sorafenib Resistance in Hepatocellular Carcinoma by Regulating \u03b2-Catenin Signaling","volume":"19","author":"Xu","year":"2020","journal-title":"Mol. Cancer"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/7\/990\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:15:06Z","timestamp":1783570506000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/7\/990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":151,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["ph19070990"],"URL":"https:\/\/doi.org\/10.3390\/ph19070990","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]}}}